Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Dravet syndrome | Statement: [CBD, EpidiolexIndication, Dravet syndrome]

Target entity: Dravet syndrome
Context triple: [CBD, EpidiolexIndication, Dravet syndrome]

• A. Huntington's chorea
  Huntington's chorea is a hereditary neurodegenerative disorder characterized by progressive motor dysfunction, cognitive decline, and psychiatric symptoms, typically manifesting in mid-adulthood.
• B. spinal muscular atrophy
  Spinal muscular atrophy is a genetic neuromuscular disorder characterized by progressive muscle weakness and atrophy due to degeneration of motor neurons in the spinal cord.
• C. SMN2
  SMN2 is a human gene that produces a backup form of survival motor neuron protein and is a key therapeutic target in spinal muscular atrophy.
• D. Spinraza
  Spinraza is a prescription medication used to treat spinal muscular atrophy (SMA) by modifying SMN2 gene expression to increase production of survival motor neuron (SMN) protein.
• E. PANS-OPS
  PANS-OPS is an ICAO document that sets international standards and criteria for designing safe and efficient instrument flight procedures for aircraft.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: Dravet syndrome
Triple: [CBD, EpidiolexIndication, Dravet syndrome]

Dravet syndrome is a rare, severe form of early-onset epilepsy characterized by prolonged, drug-resistant seizures and developmental delays, typically beginning in infancy.

Target entity: Dravet syndrome
Target entity description: Dravet syndrome is a rare, severe form of early-onset epilepsy characterized by prolonged, drug-resistant seizures and developmental delays, typically beginning in infancy.

• A. Huntington's chorea
  Huntington's chorea is a hereditary neurodegenerative disorder characterized by progressive motor dysfunction, cognitive decline, and psychiatric symptoms, typically manifesting in mid-adulthood.
• B. spinal muscular atrophy
  Spinal muscular atrophy is a genetic neuromuscular disorder characterized by progressive muscle weakness and atrophy due to degeneration of motor neurons in the spinal cord.
• C. SMN2
  SMN2 is a human gene that produces a backup form of survival motor neuron protein and is a key therapeutic target in spinal muscular atrophy.
• D. Spinraza
  Spinraza is a prescription medication used to treat spinal muscular atrophy (SMA) by modifying SMN2 gene expression to increase production of survival motor neuron (SMN) protein.
• E. PANS-OPS
  PANS-OPS is an ICAO document that sets international standards and criteria for designing safe and efficient instrument flight procedures for aircraft.
• F. None of above. chosen

Target predicate: EpidiolexIndication
Context triple: [CBD, EpidiolexIndication, Dravet syndrome]

• A. hasTargetDisease
  Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
• B. indicatedFor chosen
  Indicates...that one entity (typically a treatment, procedure, or product) is recommended or appropriate for use in relation to another entity (such as a condition, symptom, or patient group).
• C. FDAApprovalType
  Indicates the specific regulatory pathway or category under which a product has been approved by the U.S. Food and Drug Administration.
• D. isFirstDrugApprovedFor
  Indicates that a drug is the earliest or original medication approved for treating a particular condition, disease, or indication.
• E. protectedDrugClassesInclude
  Indicates that the specified set of protected drug classes includes the referenced drug class or classes.
• F. None of above.